FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W35328526> ?p ?o ?g. }

• W35328526 endingPage "917" @default.
• W35328526 startingPage "906" @default.
• W35328526 abstract "To describe the current drug interaction profiles for all approved and investigational macrolide and azalide antimicrobials, and to comment on the clinical impact of these interactions when appropriate.MEDLINE was searched to identify all pertinent studies, review articles, and case reports from 1975 to 1995. When appropriate information was not available in the literature, data were obtained from the product manufacturers.All available data were reviewed to give an unbiased account of possible drug interactions.Data for some of the interactions were not available from the literature, but were available from abstracts or from company-supplied materials. Although the data were not always entirely explicative, the best attempt was made to deliver the pertinent information that clinical practitioners would need to formulate practice opinions. When more in-depth information was supplied in the form of a review or study report, a thorough explanation of pertinent methodology was supplied.Since the introduction of erythromycin into clinical practice, there have been several clinically significant drug interactions identified throughout the literature associated with this drug. These interactions have been caused mostly by inhibition of the CYP3A subclass of hepatic enzymes, thereby decreasing the metabolism of any other agent given concurrently that is also cleared through this mechanism. With the development and marketing of several new macrolides, it was hoped that the drug interaction profile associated with this class would improve. This has been met with variable success. Although some of the extensions of the 14-membered ring macrolides have shown an incidence of interactions equal to that of erythromycin, others have shown improved profiles. In contrast, the 16-membered ring macrolides have demonstrated a much improved, though not absent, interaction profile. The most success in avoiding drug interactions through structure modification has been accomplished with the development of the azalide class, of which azithromycin is the first to be approved for marketing. This agent has to date produced none of the classic drug interactions that most macrolides have demonstrated in patient care.The introduction of new 14- and 16-membered ring macrolides appears to have had a variable effect in modifying the incidence of drug interactions associated with this class. Azithromycin, a member of the new azalide class, has to date produced fewer clinically significant interactions than other azalides with any agent that is cleared through the CYP3A system.(ABSTRACT TRUNCATED AT 250 WORDS)" @default.
• W35328526 created "2016-06-24" @default.
• W35328526 creator A5074299770 @default.
• W35328526 date "1995-09-01" @default.
• W35328526 modified "2023-10-13" @default.
• W35328526 title "Macrolides Versus Azalides: A Drug Interaction Update" @default.
• W35328526 cites W114109743 @default.
• W35328526 cites W1541951154 @default.
• W35328526 cites W165743139 @default.
• W35328526 cites W1822107371 @default.
• W35328526 cites W1964609099 @default.
• W35328526 cites W1964816152 @default.
• W35328526 cites W1966127954 @default.
• W35328526 cites W1966367464 @default.
• W35328526 cites W1967596311 @default.
• W35328526 cites W1972280475 @default.
• W35328526 cites W1976701393 @default.
• W35328526 cites W1979651453 @default.
• W35328526 cites W1985389929 @default.
• W35328526 cites W1987531347 @default.
• W35328526 cites W1990652438 @default.
• W35328526 cites W1999259571 @default.
• W35328526 cites W2005334405 @default.
• W35328526 cites W2006952590 @default.
• W35328526 cites W2007504067 @default.
• W35328526 cites W2008221075 @default.
• W35328526 cites W2009482238 @default.
• W35328526 cites W2011675869 @default.
• W35328526 cites W2013920928 @default.
• W35328526 cites W2015737559 @default.
• W35328526 cites W2018209299 @default.
• W35328526 cites W2023670162 @default.
• W35328526 cites W2024125789 @default.
• W35328526 cites W2025506048 @default.
• W35328526 cites W2027611975 @default.
• W35328526 cites W2030875178 @default.
• W35328526 cites W2033259476 @default.
• W35328526 cites W2037090150 @default.
• W35328526 cites W2038133500 @default.
• W35328526 cites W2043943868 @default.
• W35328526 cites W2044207900 @default.
• W35328526 cites W2047054951 @default.
• W35328526 cites W2049609209 @default.
• W35328526 cites W2050815455 @default.
• W35328526 cites W2057973611 @default.
• W35328526 cites W2058981384 @default.
• W35328526 cites W2060265817 @default.
• W35328526 cites W2063274005 @default.
• W35328526 cites W2072232547 @default.
• W35328526 cites W2072581244 @default.
• W35328526 cites W2072897211 @default.
• W35328526 cites W2073048333 @default.
• W35328526 cites W2074693161 @default.
• W35328526 cites W2077646228 @default.
• W35328526 cites W2080817693 @default.
• W35328526 cites W2082038223 @default.
• W35328526 cites W2082046433 @default.
• W35328526 cites W2082766880 @default.
• W35328526 cites W2090600824 @default.
• W35328526 cites W2092713010 @default.
• W35328526 cites W2095212073 @default.
• W35328526 cites W2097826031 @default.
• W35328526 cites W2098988816 @default.
• W35328526 cites W2104093795 @default.
• W35328526 cites W2120917180 @default.
• W35328526 cites W2146110014 @default.
• W35328526 cites W2155443049 @default.
• W35328526 cites W2156970133 @default.
• W35328526 cites W2414127914 @default.
• W35328526 cites W2421757031 @default.
• W35328526 cites W2511528930 @default.
• W35328526 cites W4233901727 @default.
• W35328526 cites W4234514850 @default.
• W35328526 cites W4235179957 @default.
• W35328526 doi "https://doi.org/10.1177/106002809502900913" @default.
• W35328526 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8547740" @default.
• W35328526 hasPublicationYear "1995" @default.
• W35328526 type Work @default.
• W35328526 sameAs 35328526 @default.
• W35328526 citedByCount "87" @default.
• W35328526 countsByYear W353285262012 @default.
• W35328526 countsByYear W353285262013 @default.
• W35328526 countsByYear W353285262014 @default.
• W35328526 countsByYear W353285262015 @default.
• W35328526 countsByYear W353285262016 @default.
• W35328526 countsByYear W353285262017 @default.
• W35328526 countsByYear W353285262020 @default.
• W35328526 countsByYear W353285262021 @default.
• W35328526 crossrefType "journal-article" @default.
• W35328526 hasAuthorship W35328526A5074299770 @default.
• W35328526 hasConcept C111472728 @default.
• W35328526 hasConcept C126894567 @default.
• W35328526 hasConcept C138885662 @default.
• W35328526 hasConcept C138944611 @default.
• W35328526 hasConcept C17744445 @default.
• W35328526 hasConcept C177713679 @default.
• W35328526 hasConcept C199539241 @default.
• W35328526 hasConcept C2778176773 @default.

• next